TrimRx's Blog
Tirzepatide Results After Month 1: Realistic Weight Loss Expectations
Four weeks of tirzepatide. You’\”re about to move from 2.5 mg to 5 mg, which is where the drug starts doing meaningful work.
Tirzepatide Pancreatitis: Risk Factors and Symptoms
Tirzepatide can cause acute pancreatitis, though rates in the SURMOUNT-1 trial (Jastreboff et al.
Tirzepatide How It Works: Mechanism of Action Explained
Introduction Tirzepatide is a dual agonist that activates two different gut hormone receptors at the same time: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like…
Can You Take Tirzepatide Long-Term?
Yes. Tirzepatide is FDA-approved for chronic use in both type 2 diabetes (Mounjaro) and obesity (Zepbound).
Tirzepatide Latest Research: New Indications, Trials & What’s Coming
The original tirzepatide trials targeted type 2 diabetes (SURPASS program) and obesity (SURMOUNT program).
When Will Tirzepatide Go Generic? Patent Timeline & Biosimilar Outlook
Tirzepatide (Mounjaro for diabetes, Zepbound for obesity) is Eli Lilly’s blockbuster dual GIP/GLP-1 receptor agonist. SURMOUNT-1 (Jastreboff et al.
Tirzepatide Who Should (and Shouldn’t) Take It: Eligibility & Contraindications
Introduction Tirzepatide has three FDA-approved indications as of 2026: type 2 diabetes (Mounjaro®), chronic weight management in adults with BMI 30+ or BMI 27+…
Tirzepatide Drug Interactions: What You Can and Can’t Take with It
Tirzepatide doesn’t have many serious drug interactions because it’s not metabolized through the CYP450 enzyme system the way most drugs are.
Tirzepatide Dosing Guide: Schedule, Titration & What to Expect Each Week
Tirzepatide for weight loss starts at 2.5 mg weekly and steps up every 4 weeks through 5, 7.5, 10, 12.5, and 15 mg.
